2025. A multicenter, prospective randomized controlled modified dual platform trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers (TIGERCAMP). International Journal of Tissue Repair. 1, Suppl 2 (Oct. 2025). DOI:https://doi.org/10.63676/njbsev63.